Literature DB >> 26160897

Ly6Chigh Monocytes Protect against Kidney Damage during Sepsis via a CX3CR1-Dependent Adhesion Mechanism.

Benjamin G Chousterman1, Alexandre Boissonnas2, Lucie Poupel3, Camille Baudesson de Chanville3, Julien Adam4, Nahid Tabibzadeh5, Fabrice Licata3, Anne-Claire Lukaszewicz6, Amélie Lombès3, Philippe Deterre3, Didier Payen6, Christophe Combadière2.   

Abstract

Monocytes have a crucial role in both proinflammatory and anti-inflammatory phenomena occurring during sepsis. Monocyte recruitment and activation are orchestrated by the chemokine receptors CX3CR1 and CCR2 and their cognate ligands. However, little is known about the roles of these cells and chemokines during the acute phase of inflammation in sepsis. Using intravital microscopy in a murine model of polymicrobial sepsis, we showed that inflammatory Ly6C(high) monocytes infiltrated kidneys, exhibited altered motility, and adhered strongly to the renal vascular wall in a chemokine receptor CX3CR1-dependent manner. Adoptive transfer of Cx3cr1-proficient monocyte-enriched bone marrow cells into septic Cx3cr1-depleted mice prevented kidney damage and promoted mouse survival. Modulation of CX3CR1 activation in septic mice controlled monocyte adhesion, regulated proinflammatory and anti-inflammatory cytokine expression, and was associated with the extent of kidney lesions such that the number of lesions decreased when CX3CR1 activity increased. Consistent with these results, the pro-adhesive I249 CX3CR1 allele in humans was associated with a lower incidence of AKI in patients with sepsis. These data show that inflammatory monocytes have a protective effect during sepsis via a CX3CR1-dependent adhesion mechanism. This receptor might be a new therapeutic target for kidney injury during sepsis.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  chemokine receptor; immunology; kidney dysfunction

Mesh:

Substances:

Year:  2015        PMID: 26160897      PMCID: PMC4769199          DOI: 10.1681/ASN.2015010009

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  55 in total

1.  CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms.

Authors:  S Goda; T Imai; O Yoshie; O Yoneda; H Inoue; Y Nagano; T Okazaki; H Imai; E T Bloom; N Domae; H Umehara
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.

Authors:  D H McDermott; J P Halcox; W H Schenke; M A Waclawiw; M N Merrell; N Epstein; A A Quyyumi; P M Murphy
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

3.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

4.  Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.

Authors:  D G Remick; D R Call; S J Ebong; D E Newcomb; P Nybom; J A Nemzek; G E Bolgos
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

5.  Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.

Authors:  D Moatti; S Faure; F Fumeron; M el-W Amara; P Seknadji; D H McDermott; P Debré; M C Aumont; P M Murphy; D de Prost; C Combadière
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

6.  Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions; a mechanism for selective monocyte recruitment.

Authors:  Steven M Kerfoot; Sarah E Lord; Robert B Bell; Varinder Gill; Stephen M Robbins; Paul Kubes
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

7.  Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

Authors:  Christophe Combadière; Stéphane Potteaux; Ji-Liang Gao; Bruno Esposito; Saveria Casanova; Eric J Lee; Patrice Debré; Alain Tedgui; Philip M Murphy; Ziad Mallat
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

Review 8.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Adherence influences monocyte responsiveness to interleukin-10.

Authors:  Anne-France Petit-Bertron; Catherine Fitting; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  J Leukoc Biol       Date:  2003-01       Impact factor: 4.962

10.  Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice.

Authors:  Noah Saederup; Astrid E Cardona; Kelsey Croft; Makiko Mizutani; Anne C Cotleur; Chia-Lin Tsou; Richard M Ransohoff; Israel F Charo
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

View more
  27 in total

1.  CCR2 contributes to the recruitment of monocytes and leads to kidney inflammation and fibrosis development.

Authors:  Tarcio Teodoro Braga; Matheus Correa-Costa; Reinaldo Correia Silva; Mario Costa Cruz; Meire Ioshie Hiyane; Joao Santana da Silva; Katia Regina Perez; Iolanda Midea Cuccovia; Niels Olsen Saraiva Camara
Journal:  Inflammopharmacology       Date:  2017-02-06       Impact factor: 4.473

2.  TLR4-dependent internalization of CX3CR1 aggravates sepsis-induced immunoparalysis.

Authors:  Xin-Yu Ge; Shang-Ping Fang; Miao Zhou; Jing Luo; Juan Wei; Xue-Ping Wen; Xiao-Di Yan; Zui Zou
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 3.  Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.

Authors:  Rinaldo Bellomo; Claudio Ronco; Ravindra L Mehta; Pierre Asfar; Julie Boisramé-Helms; Michael Darmon; Jean-Luc Diehl; Jacques Duranteau; Eric A J Hoste; Joannes-Boyau Olivier; Matthieu Legrand; Nicolas Lerolle; Manu L N G Malbrain; Johan Mårtensson; Heleen M Oudemans-van Straaten; Jean-Jacques Parienti; Didier Payen; Sophie Perinel; Esther Peters; Peter Pickkers; Eric Rondeau; Miet Schetz; Christophe Vinsonneau; Julia Wendon; Ling Zhang; Pierre-François Laterre
Journal:  Ann Intensive Care       Date:  2017-05-04       Impact factor: 6.925

Review 4.  Cytokine storm and sepsis disease pathogenesis.

Authors:  Benjamin G Chousterman; Filip K Swirski; Georg F Weber
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

5.  Tubular GM-CSF Promotes Late MCP-1/CCR2-Mediated Fibrosis and Inflammation after Ischemia/Reperfusion Injury.

Authors:  Leyuan Xu; Diana Sharkey; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2019-07-17       Impact factor: 10.121

Review 6.  Renal microvascular endothelial cell responses in sepsis-induced acute kidney injury.

Authors:  Grietje Molema; Jan G Zijlstra; Matijs van Meurs; Jan A A M Kamps
Journal:  Nat Rev Nephrol       Date:  2021-10-19       Impact factor: 28.314

7.  A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury.

Authors:  Bixiao Zhao; Qiongshi Lu; Yuwei Cheng; Justin M Belcher; Edward D Siew; David E Leaf; Simon C Body; Amanda A Fox; Sushrut S Waikar; Charles D Collard; Heather Thiessen-Philbrook; T Alp Ikizler; Lorraine B Ware; Charles L Edelstein; Amit X Garg; Murim Choi; Jennifer A Schaub; Hongyu Zhao; Richard P Lifton; Chirag R Parikh
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

Review 8.  The Changing Landscape of Renal Inflammation.

Authors:  Thomas Ernandez; Tanya Norton Mayadas
Journal:  Trends Mol Med       Date:  2016-01-07       Impact factor: 11.951

Review 9.  Targeting of G-protein coupled receptors in sepsis.

Authors:  Abdul Rehman; Noor Ul-Ain Baloch; John P Morrow; Pál Pacher; György Haskó
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

Review 10.  Macrophage Heterogeneity in Kidney Injury and Fibrosis.

Authors:  Yi Wen; Hong-Ru Yan; Bin Wang; Bi-Cheng Liu
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.